Premium Information is available for this item - Upgrade for $1 a day
6550-01-539-4183
Papillomav Test Kit
6550015394183 015394183 MU362-US
INC: 77777
![]()
January 2023
1

Marketplace 6550-01-539-4183
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-539-4183 1+ Documents (More...)
Test Kit 6550015394183015394183 Every Day 6550-01-539-4183 RQST Updated Every Day 6550-01-539-4183 RQST
RQST 6550-01-539 -4183 RQST Updated Every Day 6550-01-539-4183 RQST Restrictions 6550-01-539-4183
Restrictions 6550-01-539-4183
6550-01-539-4183 is a Papillomav Test Kit that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6550-01-539-4183
- Turkey (ZW01)
- Effective Date:
- 1 Apr 2006
Approved Sources 6550-01-539-4183
- Part Number
- Manufacturer
- Status
- MU362-US
- Manufacturer
- 0MXK6 - Biogenex Laboratories (Active)
- Primary Buy
- Primary Buy
Datasheet 6550-01-539-4183
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Special Features [FEAT]
- Concentrated
- Functional Description [FTLD]
- Designed For Screening Hpv Infection In Tormalin-Fixed, Paraffin-Embedded Tissue Sections
Similar Supply Items to 6550-01-539-4183


















Freight Information 6550-01-539-4183
6550-01-539-4183 has freight characteristics managed by Turkey.. 6550-01-539-4183 has a variance between NMFC and UFC when transported by rail and the description should be consulted.